| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |